Navigation Links
IDRI and PATH Enter into Research Collaboration Agreement to Evaluate Novel Adjuvants to Enhance Pandemic Influenza Vaccines
Date:6/24/2010

SEATTLE, June 25 /PRNewswire-USNewswire/ -- Two global health non-profit organizations headquartered in Seattle, Washington, the Infectious Disease Research Institute (IDRI) and PATH, have entered into a Research Collaboration Agreement to evaluate novel adjuvants for their ability to enhance the immune response of pandemic influenza vaccines in development. The collaboration supports the goal of PATH's influenza vaccine project to advance the development of promising new influenza vaccines focusing on novel technologies that can be accessible, affordable, and available to people in low-resource countries in a global outbreak. IDRI, a non-profit biotechnology organization, has developed numerous emulsion adjuvants for use with various antigens for the production of vaccines.

Influenza vaccines, against both seasonal and pandemic influenza viruses, are especially needed in developing countries where current influenza vaccines may be unavailable or unaffordable, especially in the quantities needed during a pandemic outbreak. "Adjuvants, or immunostimulants, could be used to increase the worldwide supply of influenza vaccines, and may be crucial to provide the necessary doses in the event of a pandemic," says IDRI's Founder and Head of Research and Development Dr. Steve Reed.

Under the Research Collaboration Agreement, PATH will sponsor research at IDRI to evaluate different emulsions that may work as effective adjuvants in influenza vaccines for pandemic use. IDRI will provide its proprietary emulsion formulations, and PATH, through its collaborators, will provide IDRI with vaccine candidates for evaluation with various formulations. IDRI will then conduct the studies to identify leading vaccine-adjuvant candidates.  

"We are delighted to be partnering with IDRI in this effort to identify new, affordable ways of increasing the supply of influenza vaccines in a pandemic," says Dr. Kathleen Neuzil, director of PATH's influenza vaccine project. "The collaboration is an important step toward enhancing the cost-effectiveness of influenza vaccines and expanding their availability to low-resource countries that would not otherwise be able to access them."

About IDRI – Translating science into global health solutions

IDRI is a Seattle-based not-for-profit organization committed to applying innovative science to the research and development of products to prevent, detect, and treat infectious diseases of poverty. By integrating capabilities, IDRI strives to create an efficient pathway bringing scientific innovation from the lab to the people who need it most. For more information, go to www.idri.org.

About PATH

PATH is an international nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH's work improves global health and well-being. For more information, please visit www.path.org.


'/>"/>
SOURCE Infectious Disease Research Institute (IDRI)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform
2. Concord Medical Announces New Centers Opening at Hospital Partner
3. Zydus Novel Orally Administered GLP-1 Agonist - ZYOG1 to treat Diabetes and Obesity Enters Phase I Clinical Trial
4. Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
5. TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System
6. Varian Medical Systems Equips International Oncologys First Comprehensive Cancer Center in India
7. New York State Regional Extension Center Selects Greenway
8. Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center
9. Maimonides Medical Center Implements Allscripts Care Management Solution
10. New Georgia Advanced Surgery Center Provides Women Many Unique Benefits
11. New Technology Center Increases B. Brauns Infusion Pump Capacity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
(Date:8/7/2017)... Md. , Aug. 7, 2017 ... healthcare member acquisition, retention, and engagement, announced the ... of Strategy and Product Development, effective as of ... consulting and technology implementation strategy for our clients. ... of experience in consulting and business analytics within ...
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Blue Health Intelligence (BHI) announced today ... Officer. Dr. Spiro brings over 30 years of clinical, healthcare IT, value-based care, and ... analytics solutions. , “I am thrilled to welcome Dr. Spiro to BHI,” said ...
(Date:8/16/2017)... ... 16, 2017 , ... The Data Council, the leading provider ... acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the Specialty, ... leading suppliers, brokers, distributors and retailers. The Data Council will become a part ...
(Date:8/16/2017)... York, New York (PRWEB) , ... August 16, 2017 , ... ... they could minimize its appearance with diet and exercise. In fact, cellulite can't always ... is a safer and more effective treatment available to select physicians nationwide. Dr. Kenneth ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Southeastern ... three-year grant totaling $975,000, renewing its funding from the Health Resources and Services ... This funding marks, the fourth time the HRSA administration has renewed its financial ...
(Date:8/16/2017)... , ... August 16, 2017 , ... With a new ... and ultimately, a cure. , The grants are awarded through a competitive application ... with a wide array of backgrounds and expertise in all areas relevant to PD ...
Breaking Medicine News(10 mins):